Search

everythinglearnresearchcommunity

for

Search:↓

Low SHBG and high FAI, FT, and DHEAS levels are effective in identifying PCOS.

Finasteride blocks progesterone's effect on absence seizures in rats.

Finasteride reduces testosterone conversion, progesterone lessens this, and levamisole enhances finasteride's effect.

Some overweight or obese men with long-term frontal fibrosing alopecia may have abnormal sex hormone levels.

Hormone therapy for breast cancer often leads to sexual issues like vaginal dryness and decreased libido.

SHBG may be a useful early indicator and treatment target for PCOS.

The conclusion suggests that prostate cancer should be classified by castration status and that new therapies targeting androgen receptor signaling show promise.

The exact cause of growth hormone-responsive alopecia in dogs is unclear.

The enzymes 5α-reductase and 3α/β-hydroxysteroid oxidoreductase help create brain-active substances from progesterone and testosterone, which could be used for treatment, but more research is needed to ensure their safety and effectiveness.

Certain gene variations are linked to higher male hormone levels in Chinese women with PCOS and insulin resistance.

Anti-Müllerian hormone is a specific marker for ovarian issues in women with conditions like PCOS.

Finasteride blocks progesterone production in specific tumor cells, potentially causing side effects.

A certain genetic variation is linked to a higher risk of polycystic ovarian syndrome.

Future hormone therapy trials should match the diverse needs and priorities of the gender-diverse community.

Progesterone and its metabolites affect myelin protein expression differently in male and female rat Schwann cells.

Adding anti-Müllerian hormone to PCOS criteria lowers the number of women diagnosed.

A three-month treatment with a GnRH agonist significantly lowered androgen levels and 5α-reductase activity in men with benign prostatic hyperplasia.

The research found that polycystic ovary syndrome (PCOS) has two distinct types, with one having more severe hormone and insulin issues.

Treatment with a hormone agonist can reduce excess male hormones in postmenopausal women without surgery.

Hormone therapy for transgender females increases the risk of blood clots and requires careful dosing, monitoring, and lifelong management.

Women with PCOS have higher levels of AMH in their blood and follicles, and this can help predict their risk of overreaction to fertility treatments.

Different levels of anti-Müllerian hormone can help diagnose polycystic ovary syndrome in women of different ages.

AMH levels are higher in women with PCOS and can indicate the number of small follicles in their ovaries.

Simvastatin may help manage symptoms in women with non-classic congenital adrenal hyperplasia by lowering cholesterol and certain hormone levels.

Hair levels of estradiol and progesterone are higher in premenopausal than postmenopausal women, but the difference isn't statistically significant, indicating the need for a better measurement method.

Correcting vitamin D and progesterone deficiencies can significantly improve hair loss, acne, and BPH symptoms.

Progesterone and its byproducts control a specific receptor in the brain independently of progesterone receptors, affecting conditions related to the menstrual cycle.

Both finasteride and GnRH agonist treatments reduced hair growth in women with idiopathic hirsutism, but GnRH agonist was more effective.

Blood removal and birth control pills both helped with hormone levels in women with PCOS, but birth control was better for regular periods and blood removal had fewer side effects.